Clinical Trials Browser

Completed × Non - Small Cell Lung Cancer NSCLC × durvalumab × Clear all

NCT02352948 2024-07-26

ARCTIC

Phase 3 Completed

597 enrolled 23 charts

Non - Small Cell Lung Cancer NSCLC